DesignMedix Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:DesignMedix Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013139
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
DesignMedix Inc (DesignMedix) is a biotechnology company that develop drugs to overcome drug resistance in multiple diseases including malaria and diarrhea. The company focuses on the development of malaria cure drugs, malaria preventive drugs and anti-bacterial drugs. Its malaria cure drugs provides non-toxic cure for drug-resistant malaria for patients which include children and pregnant women. The company’s malaria preventive drugs provide novel therapeutic agents that are used in prevention of liver-stage malaria in a mouse model. It develops anti bacterial drug candidates active against various microbial diseases, with initial focus on T vaginalis. DesignMedix is headquartered in Portland, Oregon, the US.

DesignMedix Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
DesignMedix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
DesignMedix Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
DesignMedix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
DesignMedix Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
DesignMedix Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
DesignMedix Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
DesignMedix Raises USD1.5 Million in Venture Financing 10
DesignMedix Raises USD0.53 Million in Venture Financing 11
Partnerships 12
DesignMedix Enters into Agreement with The National Institute of Allergy and Infectious Diseases 12
Licensing Agreements 13
DesignMedix Enters into Licensing Agreement with University of California, San Diego 13
DesignMedix Inc – Key Competitors 14
DesignMedix Inc – Key Employees 15
DesignMedix Inc – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Government and Public Interest 17
Apr 04, 2016: DesignMedix receives NIH phase I STTR grant to develop novel antimicrobial drugs 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
DesignMedix Inc, Pharmaceuticals & Healthcare, Key Facts 2
DesignMedix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
DesignMedix Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
DesignMedix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
DesignMedix Inc, Deals By Therapy Area, 2011 to YTD 2017 8
DesignMedix Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
DesignMedix Raises USD1.5 Million in Venture Financing 10
DesignMedix Raises USD0.53 Million in Venture Financing 11
DesignMedix Enters into Agreement with The National Institute of Allergy and Infectious Diseases 12
DesignMedix Enters into Licensing Agreement with University of California, San Diego 13
DesignMedix Inc, Key Competitors 14
DesignMedix Inc, Key Employees 15

★海外企業調査レポート[DesignMedix Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Wallenstam AB (WALL B):企業の財務・戦略的SWOT分析
    Summary Wallenstam AB (Wallenstam) is a construction company that offers building and property management solutions. The company's services include commercial and residential properties development, housing programs, property investment and management, urban development, property ownership services, …
  • Pascal Biosciences Inc (PAS)-製薬・医療分野:企業M&A・提携分析
    Summary Pascal Biosciences Inc (Pascal Biosciences), formerly BioMmune Technologies Inc is a biopharmaceutical company that offers discovery and development of new therapeutics that enable the body’s immune system . The company advances technologies which can control the immune activity and improve …
  • CP All Public Company Limited (CPALL):企業の財務・戦略的SWOT分析
    CP All Public Company Limited (CPALL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Seair Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Seair Inc, doing business as Dover Water Solutions, is a clean technology company that carries out research and development, production and sale of gas diffusion technologies. It focuses on commercializing advanced waste water and industrial fluid treatment solutions. The company offers high …
  • Hong Leong Bank Bhd:企業の戦略・SWOT・財務分析
    Hong Leong Bank Bhd - Strategy, SWOT and Corporate Finance Report Summary Hong Leong Bank Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Oriental Yeast Co Ltd:企業の戦略・SWOT・財務情報
    Oriental Yeast Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Oriental Yeast Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Dah Sing Bank, Limited:企業の戦略・SWOT・財務情報
    Dah Sing Bank, Limited - Strategy, SWOT and Corporate Finance Report Summary Dah Sing Bank, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Agility Clinical Inc-製薬・医療分野:企業M&A・提携分析
    Summary Agility Clinical Inc (Agility), formerly Specialty CRO Inc is a contract research organization that provides specialty consulting and clinical trial services. The company offers a wide range of customized services that includes clinical operations, biostatistics, medical monitoring, project …
  • 3M Health Information Systems Inc:医療機器:M&Aディール及び事業提携情報
    Summary 3M Health Information Systems Inc (3M HIS), a subsidiary of 3M Co, is a software and consulting services provider. The company offers healthcare technology, software and consulting services. Its services are designed for clinical documentation improvement, computer-assisted coding, mobile ph …
  • Meggitt Training Systems, Inc.:企業の戦略・SWOT・財務分析
    Meggitt Training Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary Meggitt Training Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Global Voice Group SA:企業の戦略的SWOT分析
    Global Voice Group SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Dufry AG (DUFN):企業の財務・戦略的SWOT分析
    Dufry AG (DUFN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Woodside Petroleum Ltd (WPL):石油・ガス:M&Aディール及び事業提携情報
    Summary Woodside Petroleum Ltd (Woodside) is an independent oil and gas company that explores, develops, produces and supplies energy. It explores and produces oil and gas from a portfolio of facilities in association with some of the world’s major oil and gas companies. The company operates liquefi …
  • Memphasys Ltd (MEM):医療機器:M&Aディール及び事業提携情報
    Summary Memphasys Ltd (Memphasys), formerly Nusep Holdings Ltd, is a bio-separations company that develops and commercializes membrane technology solutions. The company develops felix, a non-DNA damaging lab instrument for sperm separation that separates sperm from semen sample using electrophoresis …
  • Alfa Laval AB (ALFA):企業の財務・戦略的SWOT分析
    Alfa Laval AB (ALFA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Axela Inc:製品パイプライン分析
    Summary Axela Inc (Axela), formerly Axela Biosensors Inc is a provider of optic technology solutions. The company offers Ziplex system, Flow-thru TipChips, panelPlus TipChips, diffractive optics technology, diffractive optics sensors, panelPlus sensors and software products. It offers technical and …
  • Elite Pharmaceuticals Inc (ELTP):製薬・医療:M&Aディール及び事業提携情報
    Summary Elite Pharmaceuticals Inc (Elite) is a specialty pharmaceutical company focuses on the development of oral sustained and controlled release drug products. The company manufactures and develops generic drugs with Abbreviated New Drug Applications (ANDA) and branded drugs with New Drug Applica …
  • Selecta Biosciences Inc (SELB):企業の財務・戦略的SWOT分析
    Summary Selecta Biosciences Inc (Selecta Biosciences) is a biopharmaceutical company that develops immunotherapies and vaccines for the treatment and prevention of human diseases. The company’s pipeline products include SEL-212, SEL-403, SEL-302 and SEL-302. It utilizes synthetic vaccine particle (S …
  • ResMed Inc. (RMD):医療機器:M&Aディール及び事業提携情報
    Summary ResMed Inc. (ResMed) develops, manufactures and distributes medical equipment for the diagnosis, treatment and management respiratory disorders such as sleep-disordered breathing (SDB), sleep apnea and chronic obstructive pulmonary disease (COPD). Its major products include air flow generato …
  • Host Hotels & Resorts Inc (HST):企業の財務・戦略的SWOT分析
    Host Hotels & Resorts Inc (HST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆